NCT06115811Not yet recruiting
Radiation Treatment Plan Evaluation Learning Tool Pilot Project
Development and Assessment of a Novel, Systematic Radiation Treatment Plan Evaluation Learning Tool for Radiation Oncology Residents
Source: ClinicalTrials.gov · Last updated 22 May 2026
Brief summary (registry, in English)
This study involves both the development of a novel learning tool, the Radiation Treatment Plan Evaluation Learning Module, as well as a pilot program to validate this tool as an effective resource to teach treatment plan review and optimization to radiation oncology residents.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 30 Oct 2023
- Start date
- 15 Jun 2026
- Primary completion date
- 15 Jun 2028
- Lead sponsor
- Massachusetts General Hospital
- Diseases
- Childhood cancers
- NCT number
- NCT06115811
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 15 Jun 2026 to the primary completion date, 15 Jun 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- -The study will not include any special populations.
Who the study is looking for
- The pilot program will be open to radiation oncology resident physicians that are in their PGY-2, PGY-3, or PGY-4 year.
- All residents must have completed a breast cancer-specific radiation oncology rotation at least 3 months prior to enrollment in the pilot program in order to be eligible.
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Massachusetts General Hospital Cancer Center Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.